AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2016
Sep 26, 2016
31046_dirs_2016-09-26_3f849ac1-3e2f-4bd4-a72d-fc2ca710583e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-09-26
Reporting Person: Kovacs Shane William Charles (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-26 | Common Stock | M | 10000 | $10.85 | Acquired | 18850 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-26 | Stock Option (Right to Buy) | $10.85 | M | 10000 | Disposed | 2023-05-21 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (46384) | 46384 | Direct |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (85600) | 85600 | Direct |
| Stock Option (Right to Buy) | $30.86 | 2026-01-03 | Common Stock (80000) | 80000 | Direct |
Footnotes
F1: This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014.
F2: This option award was granted on January 28, 2014, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
F3: This option award was granted on January 2, 2015, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
F4: This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.